Fig. 8
Molecular docking experiment. (A) Molecular docking model of regorafenib and S100A11; (B) Molecular docking model of R-428 and IFI16; (C) Molecular docking model of R-428 and HSDL2
Fig. 8 | BMC Pharmacology and Toxicology
Molecular docking experiment. (A) Molecular docking model of regorafenib and S100A11; (B) Molecular docking model of R-428 and IFI16; (C) Molecular docking model of R-428 and HSDL2